Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Towards molecular stratification of pediatric T-cell lymphoblastic lymphomas based on Minimal Disseminated Disease and NOTCH1/FBXW7 mutational status: the French EURO-LB02 experience

Amélie Trinquand, Adriana Plesa, Chrystelle Abdo, Nathalie Aladjidi, Charlotte Rigaud, Aurore Touzart, Ludovic Lhermitte, Arnaud Petit, Katell Michaux, Charlotte Jung, Catherine Chassagne-Clement, Vahid Asnafi, Yves Bertrand, Nathalie Garnier, Elizabeth Macintyre
doi: https://doi.org/10.1101/2020.09.08.20189829
Amélie Trinquand
1Laboratoire d’Onco-Hématologie, AP-HP Hôpital Necker-Enfants Malades, Université de Paris and Institut Necker-Enfants Malades, Paris, France
2National Children’s Research Centre at Children’s Health Ireland, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriana Plesa
3Laboratoire d’Hématologie, Hospices Civiles de Lyon, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chrystelle Abdo
1Laboratoire d’Onco-Hématologie, AP-HP Hôpital Necker-Enfants Malades, Université de Paris and Institut Necker-Enfants Malades, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Aladjidi
4Unité d’Hématologie et Cancérologie pédiatrique/CEREVANCE, CHU Bordeaux, Bordeaux, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Rigaud
5Oncologie Pédiatrique, Institut Gustave Roussy, Villejuif
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurore Touzart
1Laboratoire d’Onco-Hématologie, AP-HP Hôpital Necker-Enfants Malades, Université de Paris and Institut Necker-Enfants Malades, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludovic Lhermitte
1Laboratoire d’Onco-Hématologie, AP-HP Hôpital Necker-Enfants Malades, Université de Paris and Institut Necker-Enfants Malades, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnaud Petit
6Service d’Hématologie et d’Oncologie pédiatrique, AP-HP, Hôpital Armand Trousseau, Sorbonne Université, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katell Michaux
7Institut d’Hématologie et d’Oncologie Pédiatrique, Hospices Civiles de Lyon, Lyon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Jung
7Institut d’Hématologie et d’Oncologie Pédiatrique, Hospices Civiles de Lyon, Lyon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Chassagne-Clement
8Département de Biopathologie, Centre Leon Berard, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vahid Asnafi
1Laboratoire d’Onco-Hématologie, AP-HP Hôpital Necker-Enfants Malades, Université de Paris and Institut Necker-Enfants Malades, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yves Bertrand
7Institut d’Hématologie et d’Oncologie Pédiatrique, Hospices Civiles de Lyon, Lyon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Garnier
7Institut d’Hématologie et d’Oncologie Pédiatrique, Hospices Civiles de Lyon, Lyon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Macintyre
1Laboratoire d’Onco-Hématologie, AP-HP Hôpital Necker-Enfants Malades, Université de Paris and Institut Necker-Enfants Malades, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: elizabeth.macintyre@aphp.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

While outcome for pediatric T lymphoblastic lymphoma (T-LBL) has improved with Acute Leukemia-type therapy, survival after relapse remains rare. Few prognostic markers have been identified and the value of Minimal Residual Disease (MRD) is less clear than in T-ALL. Mutations of NOTCH1 and/or FBXW7 (N/F) identify good prognosis T-LBL and both MRD and high-level Minimal Disseminated Disease (MDD) are reported to be of poor prognosis. We evaluated MDD status by 8-color flow cytometry (MFC) and/or digital droplet PCR (ddPCR) in 86 French pediatric T-LBL, of which N/F status was known for 65 (61 treated on the Euro-LB02 protocol). Both techniques gave identical results for MDD/MRD values above 0.1%, allowing compilation. While an MDD threshold of 1% had no prognostic significance, the 54% (44/82) of protocol-treated patients with MDD ≥0.1% had a relatively favorable outcome (overall survival/OS; p = 0.026). MDD 0.1% status had no prognostic significance in the 68% of patients with N/F mutations, whereas low/negative MDD status (9/61) identified N/F germline patients at a high risk of relapse (5-year OS of 44.4% vs 90% for MDD ≥ 0.1%,p = 0.014; and a 5-year DFS of 50% vs 90.9% respectively, p = 0.041). Combining oncogenetic and MDD status allows identification of 85% of patients with an excellent outcome (5-year OS 91.9% and DFS 95%) and 15% of N/F germline/MDD< 0.1% patients who clearly require early alternative treatment (5-year OS 44.4%; p< 0.0001 and DFS 50%; p = 0.0001).

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT00275106

Funding Statement

This study was supported by: The Necker LBL RELYE (Reseau des lymphomes de l Enfant) tissue bank is supported by IMAGINE for Margo via the SFCE, the Institut National du Cancer and the CARPEM SIRIC. Research support was provided by the League National de Recherche sur le Cancer (Enfants, Adolescents et Cancer), by Enfants et Sante and by the SFCE. The Trousseau team was supported by the Recherche en Hemopathies Malignes de l Enfant (RHME).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The EURO-LB02 protocol was a randomized controlled study, derived from the Berlin-Frankfurt-Munich BFM90 protocol but without prophylactic central nervous system irradiation, involving patients aged <22y with de-novo LBL in 8 European cooperative groups (NCT00275106). The study was interrupted prematurely due to excessive toxicity, but the prednisone arm was continued in France, with central registration of clinical data in Lyon. From 2008 onwards, prospective flow cytometry was performed centrally (Lyon) for the French cohort. Between December 2004 and December 2017, 299 patients with T-LBL were enrolled in 30 institutions of the Societe Francaise de lutte contre les Cancers et leucemies de l Enfant et de l adolescent (SFCE). As per the declaration of Helsinki, the Lyon ethics committee approved the study and signed informed consent was obtained for all patients.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

-Central registration of clinical data in Lyon for the French cohort. -Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma (PMID 28983060)

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 09, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Towards molecular stratification of pediatric T-cell lymphoblastic lymphomas based on Minimal Disseminated Disease and NOTCH1/FBXW7 mutational status: the French EURO-LB02 experience
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Towards molecular stratification of pediatric T-cell lymphoblastic lymphomas based on Minimal Disseminated Disease and NOTCH1/FBXW7 mutational status: the French EURO-LB02 experience
Amélie Trinquand, Adriana Plesa, Chrystelle Abdo, Nathalie Aladjidi, Charlotte Rigaud, Aurore Touzart, Ludovic Lhermitte, Arnaud Petit, Katell Michaux, Charlotte Jung, Catherine Chassagne-Clement, Vahid Asnafi, Yves Bertrand, Nathalie Garnier, Elizabeth Macintyre
medRxiv 2020.09.08.20189829; doi: https://doi.org/10.1101/2020.09.08.20189829
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Towards molecular stratification of pediatric T-cell lymphoblastic lymphomas based on Minimal Disseminated Disease and NOTCH1/FBXW7 mutational status: the French EURO-LB02 experience
Amélie Trinquand, Adriana Plesa, Chrystelle Abdo, Nathalie Aladjidi, Charlotte Rigaud, Aurore Touzart, Ludovic Lhermitte, Arnaud Petit, Katell Michaux, Charlotte Jung, Catherine Chassagne-Clement, Vahid Asnafi, Yves Bertrand, Nathalie Garnier, Elizabeth Macintyre
medRxiv 2020.09.08.20189829; doi: https://doi.org/10.1101/2020.09.08.20189829

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8790)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (395)
  • Infectious Diseases (except HIV/AIDS) (10567)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1756)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1845)
  • Public and Global Health (3986)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)